Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Health Care Supplies

NG2:GR

42.400 EUR 0.885 2.04%

As of 02:08:38 ET on 01/28/2015.

Snapshot for Neogen Corp (NG2)

Open: 42.914 Day's Range: 42.400 - 42.914 Volume: 0
Previous Close: 43.285 52wk Range: 25.488 - 43.504 1-Yr Rtn: +39.59%

Stock Chart for NG2

No chart data available.
  • NG2:GR 42.914
  • 1D
  • 1M
  • 1Y
43.285
Interactive NG2 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NG2

Current P/E Ratio (ttm) -
Estimated P/E(05/2015) 51.6344
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (05/2015) 0.9330
Est. PEG Ratio 3.1532
Market Cap (M EUR) 1,567.00
Shares Outstanding (M) 36.96
30 Day Average Volume 11
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/25/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NG2

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NG2

Neogen Corporation develops and markets products and services dedicated to food and animal safety. The Company's diagnostic products are used by food and animal producers to test for foodborne bacteria, food allergen, natural toxins, drug and chemical residues, plant diseases, and quality assurance.

James L HerbertChairman/CEORichard CalkPresident/COO
Steven J QuinlanVP/CFOJennifer A RiceVP/Senior Director:Research
More Company Profile & Key Executives for NG2

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
  • NG2 News

  • Industry News

No stories found
No stories found
Advertisement
Sponsored Links
Advertisements
sec ||= nil